Noguchi S - Search Results

1

Predictive factors for response to docetaxel in human breast cancers.

Noguchi S. Noguchi S. Cancer Sci. 2006 Sep;97(9):813-20. doi: 10.1111/j.1349-7006.2006.00265.x. Epub 2006 Jun 29. Cancer Sci. 2006. PMID: 16805818 Review.

2

Clonal analysis of human breast cancer by means of the polymerase chain reaction.

Noguchi S, Motomura K, Inaji H, Imaoka S, Koyama H. Noguchi S, et al. Cancer Res. 1992 Dec 1;52(23):6594-7. Cancer Res. 1992. PMID: 1423305

3

[Breast preserving operation for early breast cancer--clinical implications and biological aspects of residual tumor].

Inaji H, Koyama H, Motomura K, Noguchi S, Iwanaga T, Tsuji N, Wada A. Inaji H, et al. Among authors: noguchi s. Nihon Geka Gakkai Zasshi. 1992 Sep;93(9):1190-3. Nihon Geka Gakkai Zasshi. 1992. PMID: 1470142 Japanese.

4

[Adjuvant chemotherapy therapy of breast cancer].

Koyama H, Noguchi S, Inaji H, Motomura K, Imaoka S, Iwanaga T. Koyama H, et al. Among authors: noguchi s. Gan To Kagaku Ryoho. 1992 Jun;19(6):775-82. Gan To Kagaku Ryoho. 1992. PMID: 1605653 Japanese.

5

Surgical treatment for chest wall recurrence of breast cancer.

Miyauchi K, Koyama H, Noguchi S, Inaji H, Yamamoto H, Kodama K, Iwanaga T. Miyauchi K, et al. Among authors: noguchi s. Eur J Cancer. 1992;28A(6-7):1059-62. doi: 10.1016/0959-8049(92)90456-c. Eur J Cancer. 1992. PMID: 1627375

6

Immunohistochemical, ultrastructural and biochemical studies of an amylase-producing breast carcinoma.

Inaji H, Koyama H, Higashiyama M, Noguchi S, Yamamoto H, Ishikawa O, Omichi K, Iwanaga T, Wada A. Inaji H, et al. Among authors: noguchi s. Virchows Arch A Pathol Anat Histopathol. 1991;419(1):29-33. doi: 10.1007/BF01600149. Virchows Arch A Pathol Anat Histopathol. 1991. PMID: 1712519

7

[New factors of possible prognostic value in breast cancer].

Inaji H, Motomura K, Noguchi S, Yamamoto H, Koyama H. Inaji H, et al. Among authors: noguchi s. Gan To Kagaku Ryoho. 1992 Jan;19(1):8-13. Gan To Kagaku Ryoho. 1992. PMID: 1729961 Review. Japanese.

8

Changes in hematologic parameters during treatment with medroxyprogesterone acetate for breast cancer.

Yamamoto H, Noguchi S, Miyauchi K, Inaji H, Imaoka S, Koyama H, Iwanaga T. Yamamoto H, et al. Among authors: noguchi s. Jpn J Cancer Res. 1991 Apr;82(4):420-5. doi: 10.1111/j.1349-7006.1991.tb01865.x. Jpn J Cancer Res. 1991. PMID: 1828463 Free PMC article.

9

Inability of medroxyprogesterone acetate to down regulate estrogen receptor level in human breast cancer.

Noguchi S, Yamamoto H, Inaji H, Imaoka S, Koyama H. Noguchi S, et al. Cancer. 1990 Mar 15;65(6):1375-9. doi: 10.1002/1097-0142(19900315)65:6<1375::aid-cncr2820650621>3.0.co;2-j. Cancer. 1990. PMID: 2137722

10

[Combination therapy with 5'DFUR and MPA as a second line treatment for advanced/recurrent breast cancer].

Koyama H, Nishizawa Y, Noguchi S, Yamamoto H, Miyauchi K, Inaji H, Imaoka S, Iwanaga T. Koyama H, et al. Among authors: noguchi s. Nihon Gan Chiryo Gakkai Shi. 1990 Mar 20;25(3):655-61. Nihon Gan Chiryo Gakkai Shi. 1990. PMID: 2141052 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results